Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus

Indian Journal of Endocrinology and Metabolism

Volumn 18, Issue 1, 2014, Pages 94-98

  Abd Allha, Essam ^a   Hassan, Basma ^a   Abduo, Mohamad ^a   Omar, Seham ^a   Sliem, Hamdy ^a  

^a Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

Albuminuria; diabetes mellitus; diabetic nephropathy; small dense LDL

Indexed keywords

EID: 84995505120     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.126585     Document Type: Article

References (32)

1. King H, Aubert RE, Herman WH. Global Burden of Diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
2. Emerging Risk Factors Collaboration, Sarwar N, GaeP et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-22.
3. Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller, et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial group. Diabetes Care 2009;32:2068-74.
4. LeRoith D, Fonseca V, Vinik A. Metabolic memory in diabetes-focus on insulin. Diabetes Metab Res Rev 2005;21:85-90.
5. Anselmino m and Sillano D. The impact of pre-diabetes and diabetes on cardiovascular outcomes. Curr Vasc Pharmacol 2012;10(6):680-3
6. Wang W, Pan CY, Chen W. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health 2009;12:923-9.
7. Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP. Insulin resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects. Circulation 2000;101:975-80.
8. Wen CP, Cheng TY, Tsai SP, Hsu HL, Wang S. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care 2005;28:2756-61.
9. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low-density lipoprotein particles. J Clin Invest 1999;92:141-6.
10. Guijarro C, Keane WF. Lipid-induced glomerular injury. Nephron 1994;67:1-6.
11. Mulec H, Johnsen SA, Wiklund O. Cholesterol: A risk factor in diabetic nephropathy. Am J Kidney Dis 1003;22:196-201.
12. Ravid M, Brosh D, Revy Z. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998;158:998-1004.
13. Chaturvedi N, Fuller JH, Taskinen MR. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care 2001;24:2071-7.
14. Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: Insights from experimental data and clinical studies. Diabetes Metab 2000;26:254-64.
15. Austin MA, King MC, Vranizan KM. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
16. Kotani K, Tsuzaki K, Traniguchi N, Sakane N, LDL particle size and reactive oxygen metabolities in dyslipidemic patients. Int J Prev Med. 2012;3(3):160-6
17. Chancharme L, Therond P, Nigon F. Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol 1999;19:810-20.
18. Lichtenstein AH, Chung M, Lau J. Systematic review: Association of low-density lipoprotein sub-fractions with cardiovascular outcomes. Ann Intern Med 2009;150:474-84.
19. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002;43:1363-79.
20. Tabas I, Williams KJ, Borén J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: Update and therapeutic implications. Circulation 2007;116:1832-44.
21. Scott M, Grundy M, Luther T. Third report of the National Cholesterol Educaion Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
22. Hirano T, Naito H, Kurokawa M. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy. Atherosclerosis 1996;123:57-72.
23. Mattock M, Morrish N, Viberti GC. Prospective study of micro albuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736-41.
24. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-5.
25. Jensen T, Stender S, Deckert T. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 1988;31:142-5.
26. Jerums G, Allen TJ, Tsalamandris C, Akdeniz A, Sinha A, Gilbert R, et al. Relationship of progressively increasing albuminuria to apoprotein[a] and blood pressure in type 2 (non insulin-dependent) and type 1 (insulin-dependent) diabetic patients. Diabetologia 1993;36:1037-344.
27. Chowta NK, Pant P, Chowta MN. Microalbuminuria in diabetes mellitus: Association with age, sex, weight, and creatinine clearance. Indian J Nephrol 2009;19:53-6.
28. Hirano T, Ito Y, Koba S. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 2004;24:558-63.
29. American Diabetes Association. Nephropathy in diabetes (Position Statement). Diabetes Care 2004;27:579-83.
30. Attman PO, Knight-Gibson C, Tavella M. The compositional abnormalities of lipoproteins in diabetic renal failure. Nephrol Dial Transplant 1998;13:2833-41.
31. Nelson RG, Knowler WC, Pettitt DJ. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 1995;18:182-7.
32. Yoshino G, Hirano T, Kazumi T. Dyslipidemia in diabetes mellitus. Diabetes Res Clin Pract 1996;33:1-14.